188 bet - Colegiosete

<ウェブサイト名>

<現在の時刻>

出典: 標準

Englishフリーワードで探す詳細検索はこちら検索研究活動情報論文書籍等出版物競争的資金坂本 卓弥 サカモト タクヤ■所属部署名共同利用センター■職名助教  研究活動情報論文Dendritic Cells Pre-Pulsed With Wilms' Tumor 1 in Optimized Culture for Cancer Vaccination, Terutsugu Koya, Ippei Date, Haruhiko Kawaguchi, Asuka Watanabe, Takuya Sakamoto, Misa Togi, Tomohisa Kato Jr, Kenichi Yoshida, Shunsuke Kojima, Ryu Yanagisawa, Shigeo Koido, Haruo Sugiyama , Shigetaka Shimodaira, Pharmaceutics, 12:305, 2020年03月In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination, Shimodaira S, Yanagisawa R, Koya T, Hirabayashi K, Higuchi Y, Sakamoto T, Togi M, Kato T Jr, Kobayashi T, Koizumi T, Koido S, Sugiyama H, Vaccines (Basel), 7:120, 2019年09月Quality Verification with a Cluster-Controlled Manufacturing System to Generate Monocyte-Derived Dendritic Cells, Haruhiko Kawaguchi, Takuya Sakamoto, Terutsugu Koya, Misa Togi, Ippei Date, Asuka Watanabe, Kenichi Yoshida, Tomohisa Kato, Yuka Nakamura, Yasuhito Ishigaki, Shigetaka Shimodaira, Vaccines, 9:533, 2021年05月Identification of CD56 dim subpopulation marked with high expression of GZMB/PRF1/PI-9 in CD56 + interferon-α-induced dendritic cells, Asuka Watanabe, Misa Togi, Terutsugu Koya, Makoto Taniguchi , Takuya Sakamoto, Kuniyoshi Iwabuchi, Tomohisa Kato, Shigetaka Shimodaira, Genes to cells, 26:313-327, 2021年05月Interferon-α-Induced Dendritic Cells Generated with Human Platelet Lysate Exhibit Elevated Antigen Presenting Ability to Cytotoxic T Lymphocytes, Date I, Koya T, Sakamoto T, Togi M, Kawaguchi H, Watanabe A, Kato T Jr, Shimodaira S, Vaccines, 9:10, 2021年The Detection of Immunity against WT1 and SMAD4P130L of EpCAM+ Cancer Cells in Malignant Pleural Effusion, Terutsugu Koya, Yo Niida, Misa Togi, Kenichi Yoshida, Takuya Sakamoto, Hiroki Ura, Sumihito Togi, Tomohisa Kato Jr, Sohsuke Yamada, Haruo Sugiyama, Shigeo Koido, Shigetaka Shimodaira, International Journal of Molecular Sciences, 23:12177, 2022年10月Certificate of acceptance for the manuscript (ijms-1913863) titled: Adaptive immunity against WT1 and SMAD4P130L of EpCAM+ cancer cells in malignant pleural effusion, Koya T, Niida Y, Togi M, Yoshida K, Sakamoto T, Ura H, Togi S, Kato T Jr, Yamada S, Sugiyama H, Koido S, Shimodaira S., Int J Mol Sci., 23:12177, 2022年10月Different in vitro-generated MUTZ-3-derived dendritic cell types secrete dexosomes with distinct phenotypes and antigen presentation potencies., Sakamoto T, Koya T, Togi M, Yoshida K, Kato T Jr, Ishigaki Y, Shimodaira S., International Journal of Molecular Sciences, 11:8362, 2022年07月DOI:10.3390/ijms23158362Synovial fluid derived from human knee osteoarthritis increases the viability of human adipose-derived stem cells through upregulation of FOSL1, Hironori Kitajima, Takuya Sakamoto, Tetsuhiro Horie, Ayane Kuwano, Atsushi Fuku, Yasuhiko Taki, Yuka Nakamura, Ikuhiro Tanida, Hiroshi Sunami, Hiroaki Hirata, Yoshiyuki Tachi, Naoki Yamamoto, Yasuo Iida, Yasuhito Ishigaki, Sohsuke Yamada, Shigetaka Shimodaira, Yusuke Shimizu, Toru Ichiseki, Ayumi Kaneuji, Satoshi Osawa and Norio Kawahara, Cells, 12:330, 2023年01月DOI:10.3390/cells12020330Septic arthritis of cervical spine facet joints: A case report and review of imaging, Hironori Kitajima, Eiju Hatano, Masahito Kawaguchi, Takuya Sakamoto, Toru Ichiseki, Ayumi Kaneuji, Norio Kawahara, The American journal of case reports, 24:e941578, 2023年10月DOI:10.12659/AJCR.941578書籍等出版物樹状細胞療法と樹状細胞細胞治療認定管理士制度指定カリキュラム 第2版(菅野 仁.長村 登紀子)(長村登紀子),掛江直子,西脇聡史,田野崎隆二,室井一男,小林博人,山口照英,内田恵理子,藤原康宏,髙橋敦子,長井一浩,伊藤経夫,横濱章彦,尾上和夫,髙橋恒夫,平井雅子,丸橋隆行,小屋照継,下平滋隆,中山享之,山崎理絵,岸野光司,高梨美乃子,池田和彦,菊田 敦,菅原 桂,畠賢一郎,加畑 馨,菅野 仁,高源ゆみ,坂本卓弥,硎 美紗,加藤栄史,高見太郎,坂井田功,各務秀明,小野寺雅史,金子 新中外医学社 2021年08月競争的資金ネオ抗原由来mRNAとエクソソームによる個別化医療に資する樹状細胞ワクチンの作製文部科学省:科学研究費 若手研究研究期間:2020年 - 2022年  代表者:坂本 卓弥※閲覧上の注意:直近1~2年の業績は毎年7~9月に担当委員会が実施する点検により、後日情報を修正することがありますのでご了承ください。Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.

Sportsbet.io Japan (@sportsbet.io_japan) metamaskとは ビーベットの大相撲への賭け方 | 最新オッズやボーナス情報 stakedice
Copyright ©188 bet - Colegiosete The Paper All rights reserved.